Philadelphia, PA, December 12, 2013 /3BL Media/ – Heart failure in children is an important cause of childhood health problems and death. The Children’s Heart Failure Study Group of the Canadian Cardiovascular Society, in collaboration with the Canadian Pediatric Cardiology Association, has developed new guidelines to assist practitioners in primary care and emergency departments to recognize and successfully manage heart failure in children with undiagnosed heart disease and symptoms of possible heart failure. The guidelines are published in the December issue of the Canadian Journal of Cardiology.
“Most practitioners in primary care or emergency departments have little practical experience with the presentation or management of heart failure in children. The symptoms are dissimilar to those of adults, and are quite variable,” explains Paul F. Kantor, MBBCh, of the Stollery Children’s Hospital, University of Alberta, who led the project. “Currently, our experience is that nearly all cases of new-onset heart failure are diagnosed only when the patient has reached a state of severe decompensation, and less than 50% of children who present with such symptoms of heart failure survive for five years without cardiac transplantation. Early diagnosis and effective treatment therefore are very important, since the preservation of the heart may actually improve with earlier detection.”
Heart failure is a clinical syndrome in which the heart fails to pump blood adequately to meet the requirements of the body's organs. In children this may be present at birth or develop at any stage of childhood or adolescence. The main causes in developed countries are primary cardiomyopathies, or diseases of the heart muscle (which account for 60% of children requiring a cardiac transplant), and congenital heart diseases. The incidence of primary cardiomyopathy in developed countries is reported to be between 0.8 and 1.3 cases per 100,000 children up to the age of 18, but is ten times higher in infants up to one year old. Congenital heart disease occurs in nearly one percent of live births. Only a small percentage of these defects however are severe enough to result in heart failure during childhood.
Other causes of heart failure include systemic processes such as inflammatory diseases, metabolic disorders, endocrine derangements, and kidney disease, which result in an unknown number of cases. Ten to 14 thousand children are hospitalized every year in the United States with heart failure as one of their diagnoses. Of those, about 27% (approximately 3,000) have abnormalities of the heart muscle (including irregular heart rhythm) as an underlying cause.
On a global scale, parasitic infection, nutritional deficit, and rheumatic heart disease are the main causes of heart failure in childhood.
The symptoms of heart failure in children differ from those in adults. Two unique clinical features of heart failure in children, say the guidelines’ authors, are the possible coexistence of structural congenital heart lesions, with simultaneous over-circulation to the lungs, and under-perfusion to the body (when the two circulations are linked in parallel by an intracardiac shunt or a patent arterial duct); and a change in symptom complexes over time from infancy through adolescence. In infants and young children, these are mainly respiratory and feeding difficulties.
The guidelines group makes five recommendations to help physicians detect heart failure in children; 16 recommendations to assist in the diagnosis; and 10 recommendations for the early management of heart failure to bring it under control. The guidelines also include a table summarizing the typical features of heart failure in children, using the New York Heart Association (NYHA) and Ross classifications of functional class, and a helpful algorithm defining the treatment options for managing heart failure.
# # #
Notes for editors
“Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines,” by Paul F. Kantor, MBBCh, Jane Lougheed, MD, Adrian Dancea, MD, Michael McGillion, PhD, Nicole Barbosa, BSc, Carol Chan, BSc, Phm, Rejane Dillenburg, MD, Joseph Atallah, MD, MDCM, SM, Holger Buchholz, MD, Catherine Chant-Gambacort, MN, NP, Jennifer Conway, MD, Letizia Gardin, MD, Kristen George, BScN, Steven Greenway, MD, Derek G. Human, MBBS, Aamir Jeewa, MD, Jack F. Price, MD, Robert D. Ross, MD, S. Lucy Roche, MBChB, Lindsay Ryerson, MD, Reeni Soni, MD, Judith Wilson, BScN, and Kenny Wong, MD, Canadian Journal of Cardiology, Volume 29/Issue 12 (December 2013), DOI: http://dx.doi.org/10.1016/j.cjca.2013.08.008, published by Elsevier.
Full text of the article is available to credentialed journalists upon request. Contact Eileen Leahy at +1 732 238 3628 or firstname.lastname@example.org to obtain copies. Journalists wishing to set up interviews with the authors should contact Paul F. Kantor at +1 780 248 5431 or Paul.Kantor@albertahealthservices.ca.
About the Canadian Journal of Cardiology
The Canadian Journal of Cardiology (www.onlinecjc.ca) is the official journal of the Canadian Cardiovascular Society (www.ccs.ca). It is a vehicle for the international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as a major venue for the results of Canadian cardiovascular research and Society guidelines. The journal publishes original reports of clinical and basic research relevant to cardiovascular medicine as well as editorials, review articles, case reports, and papers on health outcomes, policy research, ethics, medical history, and political issues affecting practice.
About the Editor-in-Chief
Editor-in-Chief Stanley Nattel, MD, is Paul-David Chair in Cardiovascular Electrophysiology and Professor of Medicine at the University of Montreal and Director of the Electrophysiology Research Program at the Montreal Heart Institute Research Center.
About the Canadian Cardiovascular Society
The Canadian Cardiovascular Society is the professional association for Canadian cardiovascular physicians and scientists working to promote cardiovascular health and care through knowledge translation, professional development, and leadership in health policy. The CCS provides programs and services to its 1900+ members and others in the cardiovascular community, including guidelines for cardiovascular care, the annual Canadian Cardiovascular Congress, and, with the Canadian Cardiovascular Academy, programs for trainees. More information about the CCS and its activities can be found at www.ccs.ca.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+1 732 238 3628
KEYWORDS: Canadian Cardiovascular Society, early diagnosis, heart failure, Elsevier